4-butyrolactone has been researched along with Blood Pressure, High in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, JY; Ko, KP; Lee, J; Park, SK | 1 |
| Bai, B; Du, JR; Lei, Y; Qian, ZM; Wang, CY; Yao, Y; Yu, Y; Zong, X | 1 |
2 other study(ies) available for 4-butyrolactone and Blood Pressure, High
| Article | Year |
|---|---|
The Association between Plasma Concentration of Phytoestrogens and Hypertension within the Korean Multicenter Cancer Cohort.
Topics: 4-Butyrolactone; Asian People; Biomarkers; Case-Control Studies; Cohort Studies; Equol; Female; Humans; Hypertension; Lignans; Logistic Models; Male; Phytoestrogens; Republic of Korea; Risk | 2021 |
Ligustilide reduces phenylephrine induced-aortic tension in vitro but has no effect on systolic pressure in spontaneously hypertensive rats.
Topics: 4-Butyrolactone; Administration, Oral; Adrenergic alpha-Agonists; Animals; Aorta, Thoracic; Biological Transport; Caco-2 Cells; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Humans; Hypertension; In Vitro Techniques; Intestinal Absorption; Male; Muscle Contraction; Muscle, Smooth, Vascular; Phenylephrine; Rats; Rats, Sprague-Dawley; Systole | 2007 |